MRI device developer Biophan Technologies of Rochester, NY, is launching a new initiative to enter the market for cardiovascular diagnostics and therapeutics.
The company said it plans to both develop and acquire a range of devices and technologies for therapeutic and diagnostic applications, and market these devices to major medical device manufacturers.
By AuntMinnie.com staff writers
July 28, 2005
Related Reading
Biophan inks deal with Boston Scientific, July 1, 2005
Biophan finalizes MRA stent license, July 1, 2005
Biophan adds to patent portfolio, May 27, 2005
Biophan to license MRA stent technology, May 16, 2005
Biophan unveils next-generation Squiggle, April 7, 2005
Copyright © 2005 AuntMinnie.com